Marker Therapeutics所有資訊

Marker Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-New Enterprise Associates 16, L.P.(12.0%),NEA Partners 16, L.P.(12.0%)等

05/17 18:28 (美東)

Marker Therapeutics | 3：首次持股聲明-高管 Lurier Eliot M

2023/07/05 16:22 (美東)

Marker Therapeutics | 4：持股變動聲明-董事 Eansor Norman David

2023/06/08 21:35 (美東)

Marker Therapeutics | 4：持股變動聲明-董事 Knobil Katharine

2023/06/08 21:34 (美東)

Marker Therapeutics | 4：持股變動聲明-董事 Wilson John Robert

2023/06/08 21:33 (美東)

Marker Therapeutics | 4：持股變動聲明-董事 ELMS STEVE

2023/06/08 21:32 (美東)

Marker Therapeutics | 4：持股變動聲明-高管 Vera Juan

2023/05/11 18:10 (美東)

Marker Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Aisling Capital IV, LP(5.46%),Steve Elms(5.46%)等

2023/03/03 16:30 (美東)

Marker Therapeutics | 4：持股變動聲明

2023/03/01 16:52 (美東)

Marker Therapeutics | 4：持股變動聲明

2023/03/01 16:51 (美東)

Marker Therapeutics | 4：持股變動聲明

2023/03/01 16:50 (美東)

Marker Therapeutics | 4：持股變動聲明

2023/03/01 16:49 (美東)

Marker Therapeutics | 4：持股變動聲明

2023/03/01 16:48 (美東)

Marker Therapeutics | 4：持股變動聲明

2023/03/01 16:47 (美東)

Marker Therapeutics | 4：持股變動聲明

2022/05/26 16:12 (美東)

Marker Therapeutics | 4：持股變動聲明

2022/05/26 16:10 (美東)

Marker Therapeutics | 4：持股變動聲明

2022/05/26 16:10 (美東)

Marker Therapeutics | 4：持股變動聲明

2022/05/26 16:09 (美東)

Marker Therapeutics | 4：持股變動聲明

2022/05/26 16:08 (美東)

Marker Therapeutics | 4：持股變動聲明

2022/03/28 21:06 (美東)